Literature DB >> 33369665

Ki67 Assessment in Breast Cancer: Are We There Yet?

Jorge S Reis-Filho1, Nancy E Davidson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33369665      PMCID： PMC8246841          DOI： 10.1093/jnci/djaa202

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  14 in total

1.  Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

Authors:  Mitch Dowsett; Ian E Smith; Stephen R Ebbs; J Michael Dixon; Anthony Skene; Roger A'Hern; Janine Salter; Simone Detre; Margaret Hills; Geraldine Walsh
Journal:  J Natl Cancer Inst       Date:  2007-01-17       Impact factor: 13.506

2.  Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer.

Authors:  Emily S Reisenbichler; Gang Han; Andrew Bellizzi; Veerle Bossuyt; Jane Brock; Kimberly Cole; Oluwole Fadare; Omar Hameed; Krisztina Hanley; Beth T Harrison; M Gabriela Kuba; Amy Ly; Dylan Miller; Mirna Podoll; Anja C Roden; Kamaljeet Singh; Mary Ann Sanders; Shi Wei; Hannah Wen; Vasiliki Pelekanou; Vesal Yaghoobi; Fahad Ahmed; Lajos Pusztai; David L Rimm
Journal:  Mod Pathol       Date:  2020-04-16       Impact factor: 7.842

Review 3.  Gene expression profiling in breast cancer: classification, prognostication, and prediction.

Authors:  Jorge S Reis-Filho; Lajos Pusztai
Journal:  Lancet       Date:  2011-11-19       Impact factor: 79.321

4.  An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.

Authors:  David L Rimm; Samuel C Y Leung; Lisa M McShane; Yalai Bai; Anita L Bane; John M S Bartlett; Jane Bayani; Martin C Chang; Michelle Dean; Carsten Denkert; Emeka K Enwere; Chad Galderisi; Abhi Gholap; Judith C Hugh; Anagha Jadhav; Elizabeth N Kornaga; Arvydas Laurinavicius; Richard Levenson; Joema Lima; Keith Miller; Liron Pantanowitz; Tammy Piper; Jason Ruan; Malini Srinivasan; Shakeel Virk; Ying Wu; Hua Yang; Daniel F Hayes; Torsten O Nielsen; Mitch Dowsett
Journal:  Mod Pathol       Date:  2018-08-24       Impact factor: 7.842

5.  Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.

Authors:  Mitch Dowsett; Torsten O Nielsen; Roger A'Hern; John Bartlett; R Charles Coombes; Jack Cuzick; Matthew Ellis; N Lynn Henry; Judith C Hugh; Tracy Lively; Lisa McShane; Soon Paik; Frederique Penault-Llorca; Ljudmila Prudkin; Meredith Regan; Janine Salter; Christos Sotiriou; Ian E Smith; Giuseppe Viale; Jo Anne Zujewski; Daniel F Hayes
Journal:  J Natl Cancer Inst       Date:  2011-09-29       Impact factor: 13.506

6.  Breast cancer molecular profiling with single sample predictors: a retrospective analysis.

Authors:  Britta Weigelt; Alan Mackay; Roger A'hern; Rachael Natrajan; David S P Tan; Mitch Dowsett; Alan Ashworth; Jorge S Reis-Filho
Journal:  Lancet Oncol       Date:  2010-02-22       Impact factor: 41.316

7.  Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).

Authors:  Matthew J Ellis; Vera J Suman; Jeremy Hoog; Rodrigo Goncalves; Souzan Sanati; Chad J Creighton; Katherine DeSchryver; Erika Crouch; Amy Brink; Mark Watson; Jingqin Luo; Yu Tao; Michael Barnes; Mitchell Dowsett; G Thomas Budd; Eric Winer; Paula Silverman; Laura Esserman; Lisa Carey; Cynthia X Ma; Gary Unzeitig; Timothy Pluard; Pat Whitworth; Gildy Babiera; J Michael Guenther; Zoneddy Dayao; David Ota; Marilyn Leitch; John A Olson; D Craig Allred; Kelly Hunt
Journal:  J Clin Oncol       Date:  2017-01-03       Impact factor: 44.544

8.  Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

Authors:  Pratyaksha Wirapati; Christos Sotiriou; Susanne Kunkel; Pierre Farmer; Sylvain Pradervand; Benjamin Haibe-Kains; Christine Desmedt; Michail Ignatiadis; Thierry Sengstag; Frédéric Schütz; Darlene R Goldstein; Martine Piccart; Mauro Delorenzi
Journal:  Breast Cancer Res       Date:  2008-07-28       Impact factor: 6.466

9.  Ki-67 acts as a biological surfactant to disperse mitotic chromosomes.

Authors:  Sara Cuylen; Claudia Blaukopf; Antonio Z Politi; Thomas Müller-Reichert; Beate Neumann; Ina Poser; Jan Ellenberg; Anthony A Hyman; Daniel W Gerlich
Journal:  Nature       Date:  2016-06-29       Impact factor: 49.962

10.  Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial.

Authors:  Ian Smith; John Robertson; Lucy Kilburn; Maggie Wilcox; Abigail Evans; Chris Holcombe; Kieran Horgan; Cliona Kirwan; Elizabeth Mallon; Mark Sibbering; Anthony Skene; Raghavan Vidya; Maggie Cheang; Jane Banerji; James Morden; Kally Sidhu; Andrew Dodson; Judith M Bliss; Mitch Dowsett
Journal:  Lancet Oncol       Date:  2020-11       Impact factor: 41.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.